Abstract
Whether treatment of hyperglycaemia prevents progression of diabetic nephropathy is controversial. Intensive glycaemic control reduces the risk of microalbuminuria and macroalbuminuria, but there is no clear-cut evidence showing that it reduces doubling of serum creatinine levels or risk of death from kidney disease. Larger studies or further follow-up of previous trials are required to better assess renal outcomes.
| Original language | English |
|---|---|
| Pages (from-to) | 515-516 |
| Number of pages | 2 |
| Journal | Nature Reviews Endocrinology |
| Volume | 8 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - Sep 2012 |
| Externally published | Yes |
Cite this
}
Diabetes : Treating diabetic nephropathy-still an unresolved issue. / Cooper, Mark E.
In: Nature Reviews Endocrinology, Vol. 8, No. 9, 09.2012, p. 515-516.Research output: Contribution to journal › Review Article › Other › peer-review
TY - JOUR
T1 - Diabetes
T2 - Treating diabetic nephropathy-still an unresolved issue
AU - Cooper, Mark E.
PY - 2012/9
Y1 - 2012/9
N2 - Whether treatment of hyperglycaemia prevents progression of diabetic nephropathy is controversial. Intensive glycaemic control reduces the risk of microalbuminuria and macroalbuminuria, but there is no clear-cut evidence showing that it reduces doubling of serum creatinine levels or risk of death from kidney disease. Larger studies or further follow-up of previous trials are required to better assess renal outcomes.
AB - Whether treatment of hyperglycaemia prevents progression of diabetic nephropathy is controversial. Intensive glycaemic control reduces the risk of microalbuminuria and macroalbuminuria, but there is no clear-cut evidence showing that it reduces doubling of serum creatinine levels or risk of death from kidney disease. Larger studies or further follow-up of previous trials are required to better assess renal outcomes.
UR - http://www.scopus.com/inward/record.url?scp=84865223234&partnerID=8YFLogxK
U2 - 10.1038/nrendo.2012.125
DO - 10.1038/nrendo.2012.125
M3 - Review Article
VL - 8
SP - 515
EP - 516
JO - Nature Reviews Endocrinology
JF - Nature Reviews Endocrinology
SN - 1759-5029
IS - 9
ER -